Clinical Significance of Serum Kallistatin and ENOX1 Levels in Patients with Coronary Heart Disease

Abstract

<b><i>Background:</i></b> Kallistatin and ENOX1 are regulators of inflammation and oxidative stress which are typical pathological reactions in atherosclerosis. However, there is limited information of kallistatin and ENOX1 in coronary heart disease (CHD). <b><i>Methods:</i></b> Fifty healthy controls, 56 stable angina pectoris (SAP) patients, and 47 acute coronary syndrome (ACS) patients were included in this study. Levels of kallistatin and ENOX1 in serum were measured by ELISA. χ² test was performed to analyze categorical data. ANOVA, Pearson correlation analysis, and multiple linear regression were performed to analyze the numerical data. Finally, receiver operating characteristic (ROC) curve was applied to assess the diagnostic value of kallistatin in CHD. <b><i>Results:</i></b> Among the 153 participants, 59.5% were male and the average age was 63.8 ± 11.39 years. Compared with the control group, kallistatin expression was decreased in the SAP and ACS groups while expression of ENOX1 was increased in the ACS group (<i>p</i> &#x3c; 0.05). Pearson correlation analysis showed that the kallistatin level was negatively correlated with the Gensini score (<i>r</i> = −0.210, <i>p</i> &#x3c; 0.01), white blood cell (WBC) count (<i>r</i> = −0.283, <i>p</i> &#x3c; 0.001), and triglyceride levels (<i>r</i> = −0.242, <i>p</i> &#x3c; 0.01) and positively correlated with age (<i>r</i> = 0.353, <i>p</i> &#x3c; 0.001) and high-density lipoprotein cholesterol (<i>r</i> = 0.310, <i>p</i> &#x3c; 0.001). ENOX1 expression was positively correlated with WBC count (<i>r</i> = 0.244, <i>p</i> &#x3c; 0.01), international normalized ratio (<i>r</i> = 0.177, <i>p</i> &#x3c; 0.05), and Gensini score (<i>r</i> = 0.201, <i>p</i> &#x3c; 0.05). Multiple linear regression showed that Cr, alanine transaminase, glucose, and kallistatin are independent predictors for Gensini score. The ROC curve showed that kallistatin had the highest diagnostic significance (<i>p</i> = 0.007) when the area under curve was 0.636, with a sensitivity of 0.735 and a specificity of 0.495. <b><i>Conclusion:</i></b> Expression of kallistatin was decreased in CHD patients and that of ENOX1 was increased in ACS patients. Kallistatin and ENOX1 were closely connected with the severity of CHD, and kallistatin may be helpful in the diagnosis of CHD.